Coping with genetic diversity: The contribution of pathogen and human genomics to modern vaccinology

Brazilian Journal of Medical and Biological Research

Volumn 45, Issue 5, 2012, Pages 376-385

  Lemaire, D ^a   Barbosa, T ^b   Rihet, P ^c  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Genetic variation; Human vaccines; Immunization; Vaccinomics

Indexed keywords

BCG VACCINE;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN DETECTION; BACTERIAL GENOME; BIOINFORMATICS; CHROMOSOME 10Q; CHROMOSOME 15Q; CHROMOSOME 22Q; CHROMOSOME 5Q; CHROMOSOME 6Q; CHROMOSOME 8Q; COMPUTER ANALYSIS; DNA SEQUENCE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC REGULATION; GENETIC SCREENING; GENETIC TRAIT; GENETIC VARIABILITY; HAEMOPHILUS INFLUENZAE; HERITABILITY; HIGH THROUGHPUT SEQUENCING; HOST PATHOGEN INTERACTION; HUMAN; HUMORAL IMMUNITY; IMMUNE EVASION; INFECTION RISK; MOLECULAR BIOLOGY; MYCOBACTERIUM TUBERCULOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; PHARMACOGENOMICS; PROTEOMICS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; VACCINE PRODUCTION; VIRUS GENOME;

EID: 84861120719     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2011007500142     Document Type: Review

References (69)

1. Rappuoli R, Aderem A. A 2020 vision for vaccines against HIV, tuberculosis and malaria. Nature 2011; 473: 463-469.
2. Liolios K, Chen IM, Mavromatis K, Tavernarakis N, Hugenholtz P, Markowitz VM, et al. The Genomes On Line Data-base (GOLD) in 2009: status of genomic and metagenomic projects and their associated metadata. Nucleic Acids Res 2010; 38: D346-D354.
3. Knaust A, Frosch M. Genome-based vaccines. Int J Med Microbiol 2004; 294: 295-301.
4. Kennedy RB, Poland GA. The top five game changers in vaccinology: toward rational and directed vaccine development. OMICS. http://www.ncbi.nlm.nih.gov/pubmed/21815811. Accessed September 1, 2011.
5. Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlavage AR, et al. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 1995; 269: 496-512.
6. Rappuoli R, Covacci A. Reverse vaccinology and genomics. Science 2003; 302: 602.
7. Gupta A, Chaukiker D, Singh TR. Comparative analysis of epitope predictions: proposed library of putative vaccine candidates for HIV. Bioinformation 2011; 5: 386-389.
8. Pizza M, Scarlato V, Masignani V, Giuliani MM, Arico B, Comanducci M, et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000; 287: 1816-1820.
9. Harrison LH. Epidemiological profile of meningococcal disease in the United States. Clin Infect Dis 2010; 50 (Suppl 2): S37-S44.
10. Giuliani MM, Adu-Bobie J, Comanducci M, Arico B, Savino S, Santini L, et al. A universal vaccine for serogroup B meningococcus. Proc NatlAcad Sci U SA 2006; 103: 10834-10839.
11. Kimura A, Toneatto D, Kleinschmidt A, Wang H, Dull P. Immunogenicity and safety of a multicomponent meningococ- cal serogroup B vaccine and a quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135, and Y in adults who are at increased risk for occupational exposure to meningococcal isolates. Clin Vaccine Immunol 2011; 18: 483-486.
12. Rinaudo CD, Telford JL, Rappuoli R, Seib KL. Vaccinology in the genome era. J Clin Invest 2009; 119: 2515-2525.
13. Sylvester-Hvid C, Nielsen M, Lamberth K, Roder G, Justesen S, Lundegaard C, et al. SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. Tissue Antigens 2004; 63: 395-400.
14. Fischer W, Perkins S, Theiler J, Bhattacharya T, Yusim K, Funkhouser R, et al. Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants. Nat Med 2007; 13: 100-106.
15. Bhatia V, Sinha M, Luxon B, Garg N. Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening. Infect Immun 2004; 72: 6245-6254.
16. Mu J, Awadalla P, Duan J, McGee KM, Keebler J, Seydel K, et al. Genome-wide variation and identification of vaccine targets in the Plasmodium falciparum genome. Nat Genet 2007; 39: 126-130.
17. Kremer K, van-der-Werf MJ, Au BK, Anh DD, Kam KM, van-Doom HR, et al. Vaccine-induced immunity circumvented by typical Mycobacterium tuberculosis Beijing strains. Emerg Infect Dis 2009: 15: 335-339.
18. Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995; 346: 1339-1345.
19. Maione D, Margarit I, Rinaudo CD, Masignani V, Mora M, Scarselli M, et al. Identification of a universal Group B streptococcus vaccine by multiple genome screen. Science 2005; 309: 148-150.
20. Bambini S, Rappuoli R. The use of genomics in microbial vaccine development. Drug Discov Today 2009; 14: 252-260.
21. Hanage WP, Finkelstein JA, Huang SS, Pelton SI, Stevenson AE, Kleinman K, et al. Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete. Epidemics 2010; 2: 80-84.
22. Casanova JL, Abel L. Human genetics of infectious diseases: a unified theory. EMBO J 2007; 26: 915-922.
23. Bowcock AM. Genome-wide association studies and infectious disease. Crit Rev lmmunol 2010; 30: 305-309.
24. Hong-Geller E, Micheva-Viteva SN. Functional gene discovery using RNA interference-based genomic screens to combat pathogen infection. Curr Drug Discov Technol 2010; 7: 86-94.
25. Marquet S, Abel L, Hillaire D, Dessein H, Kalil J, Feingold J, et al. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31q33. Nat Genet 1996; 14: 181-184.
26. Dessein AJ, Hillaire D, Elwali NE, Marquet S, Mohamed-Ali Q, Mirghani A, et al. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene. Am J Hum Genet 1999; 65: 709-721.
27. Baghdadi JE, Orlova M, Alter A, Ranque B, Chentoufi M, Lazrak F, et al. An autosomal dominant major gene confers predisposition to pulmonary tuberculosis in adults. J Exp Med 2006; 203: 1679-1684.
28. Bellamy R, Beyers N, McAdam KP, Ruwende C, Gie R, Samaai P, et al. Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. Proc Natl Acad Sci U S A 2000; 97: 8005-8009.
29. Siddiqui MR, Meisner S, Tosh K, Balakrishnan K, Ghei S, Fisher SE, et al. A major susceptibility locus for leprosy in India maps to chromosome 10p13. Nat Genet 2001; 27: 439-441.
30. Mira MT, Alcais A, Van Thuc N, Thai VH, Huong NT, Ba NN, et al. Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population. Nat Genet 2003; 33: 412-415.
31. Bucheton B, Abel L, EI-Safi S, Kheir MM, Pavek S, Lemainque A, et al. A major susceptibility locus on chromosome 22q12 plays a critical role in the control of kala-azar. Am J Hum Genet 2003; 73: 1052-1060.
32. Rihet P. Innate immunity genes as candidate genes: searching for relevant natural polymorphisms in databases and assessing family-based association of polymorphisms with human diseases. Methods MolBiol2008; 415: 17-48.
33. Sakuntabhai A, Ndiaye R, Casademont I, Peerapittayamongkol C, Rogier C, Tortevoye P, et al. Genetic determination and linkage mapping of Plasmodium falciparum malaria related traits in Senegal. PLoS One 2008; 3: e2000.
34. Flori L, Sawadogo S, Esnault C, Delahaye NF, Fumoux F, Rihet P. Linkage of mild malaria to the major histocompatibility complex in families living in Burkina Faso. Hum Mol Genet 2003; 12: 375-378.
35. Jallow M, Teo YY, Small KS, Rockett KA, Deloukas P, Clark TG, et al. Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet 2009; 41: 657-665.
36. Kouriba B, Chevillard C, Bream JH, Argiro L, Dessein H, Arnaud V, et al. Analysis of the 5q31-q33 locus shows an association between IL13-1055C/T IL-13-591A/G polymorphisms and Schistosoma haematobium infections. J Immunol 2005; 174: 6274-6281.
37. Flori L, Delahaye NF, Iraqi FA, Hernandez-Valladares M, Fumoux F, Rihet P. TNF as a malaria candidate gene: polymorphism-screening and family-based association analysis of mild malaria attack and parasitemia in Burkina Faso. Genes Immun 2005; 6: 472-480.
38. Delahaye NF, Barbier M, Fumoux F, Rihet P. Association analyses of NCR3 polymorphisms with P. falciparum mild malaria. Microbes Infect 2007; 9: 160-166.
39. Mira MT, Alcais A, Nguyen VT, Moraes MO, Di Flumeri C, Vu HT, et al. Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 2004; 427: 636-640.
40. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007; 317: 944-947.
41. Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 2009; 41: 591-595.
42. Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 2009; 41: 1105-1109.
43. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009; 461: 798-801.
44. Poland GA, Ovsyannikova IG, Jacobson RM, Smith DI. Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics. Clin Pharmacol Ther 2007; 82: 653-664.
45. Hohler T, Reuss E, Evers N, Dietrich E, Rittner C, Freitag CM, et al. Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins. Lancet 2002; 360: 991-995.
46. Newport MJ, Goetghebuer T, Weiss HA, Whittle H, Siegrist CA, Marchant A. Genetic regulation of immune responses to vaccines in early life. Genes lmmun 2004; 5: 122-129.
47. Hennig BJ, Fielding K, Broxholme J, Diatta M, Mendy M, Moore C, et al. Host genetic factors and vaccine-induced immunity to hepatitis B virus infection. PLoS One 2008; 3: e1898.
48. Awadalla P. The evolutionary genomics of pathogen recombination. Nat Rev Genet 2003; 4: 50-60.
49. Poland GA, Ovsyannikova IG, Jacobson RM. Vaccine immunogenetics: bedside to bench to population. Vaccine 2008; 26: 6183-6188.
50. Modiano D, Luoni G, Sirima BS, Lanfrancotti A, Petrarca V, Cruciani F, et al. The lower susceptibility to Plasmodium falciparum malaria of Fulani of Burkina Faso (west Africa) is associated with low frequencies of classic malaria-resistance genes. Trans R Soc Trop Med Hyg 2001; 95: 149-152.
51. Poland GA, Jacobson RM, Colbourne SA, Thampy AM, Lipsky JJ, Wollan PC, et al. Measles antibody seroprevalence rates among immunized Inuit, Innu and Caucasian subjects. Vaccine 1999; 17: 1525-1531.
52. Black GF, Weir RE, Floyd S, Bliss L, Warndorff DK, Crampin AC, et al. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 2002: 359: 1393-1401.
53. Galil K, Singleton R, Levine OS, Fitzgerald MA, Bulkow L, Getty M, et al. Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska. J Infect Dis 1999; 179: 101-106
54. Poland GA, Ovsyannikova IG, Jacobson RM. Adversomics: the emerging field of vaccine adverse event immunogenetics. Pediatr Infect Dis J 2009; 28: 431-432.
55. Depristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. http://www.ncbi.nlm.nih.gov/pubmed/21478889. Accessed April 13, 2011.
56. Balding DJ. A tutorial on statistical methods for population association studies. Nat Rev Genet 2006; 7: 781-791.
57. Kwiatkowski DP. How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet 2005; 77: 171-192.
58. Chang AN. Prioritizing genes for pathway impact using network analysis. Methods Mol Biol 2009; 563: 141-156.
59. Kara E, Ozturk NC, Ozgur A, Yildiz A, Ozturk H. Ectopic kidney with varied vasculature: demonstrated by CT angiography. Surg Radiol Anat 2011; 33: 81-84.
60. Caws M, Thwaites G, Dunstan S, Hawn TR, Lan NT, Thuong NT, et al. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog 2008; 4: e1000034.
61. Vidal M, Cusick ME, Barabasi AL. Interactome networks and human disease. Cell 2011; 144: 986-998.
62. Delahaye NF, Coltel N, Puthier D, Barbier M, Benech P, Joly F, et al. Gene expression analysis reveals early changes in several molecular pathways in cerebral malaria-susceptible mice versus cerebral malaria-resistant mice. BMC Genomics 2007; 8: 452.
63. Delahaye NF, Coltel N, Puthier D, Flori L, Houlgatte R, Iraqi FA, et al. Gene-expression profiling discriminates between cerebral malaria (CM)-susceptible mice and CM-resistant mice. J Infect Dis 2006; 193: 312-321.
64. Chaussabel D, Pascual V, Banchereau J. Assessing the human immune system through blood transcriptomics. BMC Biol 2010; 8: 84.
65. Fletcher HA, Keyser A, Bowmaker M, Sayles PC, Kaplan G, Hussey G, et al. Transcriptional profiling of mycobacterial antigen-induced responses in infants vaccinated with BCG at birth. BMC Med Genomics 2009; 2: 10.
66. Lynn DJ, Chan C, Naseer M, Yau M, Lo R, Sribnaia A, et al. Curating the innate immunity interactome. BMC Syst Biol 2010; 4: 117.
67. Oberg AL, Kennedy RB, Li P, Ovsyannikova IG, Poland GA. Systems biology approaches to new vaccine development. Curr Opin Immunol 2011; 23: 436-443.
68. Querec TD, Akondy RS, Lee EK, Cao W, Nakaya HI, Teuwen D, et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 2009; 10: 116-125.
69. Nakaya HI, Wrammert J, Lee EK, Racioppi L, Marie-Kunze S, Haining WN, et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 2011; 12: 786-795.